FABBRI SAVERIO

Tognola, C., Myriam Intravaia, R., Senini, E., Pezzoli, S., Riccio, A., Gualini, E., et al. (2025). Secondary prevention and extreme cardiovascular risk evaluation (SEVERE-0): Prevalence of extreme cardiovascular risk in cardiological rehabilitation patients and its impact on functional improvement. NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 35(2 (February 2025)) [10.1016/j.numecd.2024.08.006]. Dettaglio

Maloberti, A., Toscani, G., Busti, A., Tognola, C., Intravaia, R., De Censi, L., et al. (2024). EFFECT OF ANTI-PCSK9 ANTIBODIES ON ARTERY STRUCTURE AND FUNCTION: THE NIGUARDA HOSPITAL COHORT. In ESH 2024 Abstract Book (pp.299-299). LIPPINCOTT WILLIAMS & WILKINS [10.1097/01.hjh.0001022608.48617.b6]. Dettaglio

Fortuna, M., Tognola, C., Algeri, M., Shkodra, A., Intravaia, R., Pezzoli, S., et al. (2024). Hyperuricemia in Cardiac Rehabilitation Patients: Prevalence and Association with Functional Improvement and Left Ventricular Ejection Fraction. HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 31(5), 461-471 [10.1007/s40292-024-00665-x]. Dettaglio

Maloberti, A., Ciampi, C., Politi, F., Fabbri, S., Musca, F., Giannattasio, C. (2024). Cardiac amyloidosis red flags: What all the cardiologist have to know. INTERNATIONAL JOURNAL OF CARDIOLOGY. CARDIOVASCULAR RISK AND PREVENTION, 21(June 2024) [10.1016/j.ijcrp.2024.200271]. Dettaglio

Abrignani, M., Maloberti, A., Fusco, S., Luca, F., Cesaro, A., Acerbo, V., et al. (2024). Lipoproteina(a): associazione con la malattia aterosclerotica e valvolare e terapie emergenti. GIORNALE ITALIANO DI CARDIOLOGIA, 25(2), 76-87 [10.1714/4187.41756]. Dettaglio